Who is sponsoring NCT07325227?

NCT07325227 is sponsored by Fred E, Shapiro.

What drugs are being tested in NCT07325227?

Interventions in NCT07325227: Arm 1 Cataract Surgery performed with remimazolam as sedative, Arm 2 Cataract Surgery performed with standard of care sedative.

What condition does NCT07325227 study?

NCT07325227 studies Cataract Surgery Anesthesia.

Is NCT07325227 still recruiting?

NCT07325227 is currently not yet recruiting. Last updated 8 January 2026.

Last reviewed 2026-01-08 · How we verify

NCT07325227

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study of Remimazolam for Cataract Surgery

Not yet recruiting Phase 4 Last updated 8 January 2026

What this trial tests

Phase 4 trial testing Arm 1 Cataract Surgery performed with remimazolam as sedative in Cataract Surgery Anesthesia in 30 participants. Not yet recruiting.

Timeline

15 February 2026

Primary endpoint
31 January 2027

1 December 2027

Quick facts

Lead sponsor	Fred E, Shapiro
Phase	Phase 4
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	prevention
Enrollment	30
Start date	15 February 2026
Primary completion	31 January 2027
Estimated completion	1 December 2027
Sites	1 location across United States

Drugs / interventions tested

Arm 1 Cataract Surgery performed with remimazolam as sedative — full drug profile →
Arm 2 Cataract Surgery performed with standard of care sedative — full drug profile →

Conditions studied

Cataract Surgery Anesthesia — all drugs for Cataract Surgery Anesthesia →

Sponsor

Fred E, Shapiro — full company profile →

Who can join

Adults 55 to 90, any sex, with Cataract Surgery Anesthesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to learn if the use of the sedative remimazolam improves the safety of patients having cataract surgery by decreasing the number of sedation-related complications during and after surgery, and shortening post-surgical cognitive recovery time.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cataract Surgery Anesthesia

Currently open trials in the same condition.

NCT07036367 — The Use of Sublingual Melatonin Premedication in Geriatric Cataract Surgery · Phase 4 · recruiting
NCT06874452 — An Extension Test of Whether to Use Oral Anti-anxiety Drugs (XANAX) When Patients Choose Second Eye Cataract Surgery Aft · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07325227 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fred E, Shapiro
Last refreshed: 8 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07325227.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing